Brief: Onward Medical Submits De Novo Application To FDA For Its Arc-Ex® System
02/04/2024 06:43
April 2 (Reuters) - Onward Medical NV ONWD.BR :
* SUBMITS DE NOVO APPLICATION TO FDA FOR ITS ARC-EX® SYSTEM
* FDA CLEARANCE WOULD ALLOW COMPANY TO MARKET THERAPY TO
IMPROVE
OR RESTORE HAND AND ARM FUNCTION AFTER SPINAL CORD INJURY IN THE
US
Source text for Workspace: urn:newsml:reuters.com:*:nGNE7411gn
Further company coverage: ONWD.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
Recent news on ONWARD Medical
See all newsBrief: Onward Medical Primary ABB Final Deal Size Was C.Eur 50m / 11.3m Shares, Says Bookrunner
Brief: Ottobock Invests EUR 10 Million In Onward Medical
Brief: Bookrunner Says Onward Medical Primary ABB Books Covered, Further Guidance To Follow
Brief: ONWARD Medical Receives FDA De Novo Classification
Brief: Onward Medical Says Receives FDA De Novo Classification And US Market Authorization For ARC-EX System